DK Fundamental Analysis - DELEK US HOLDINGS INC

Fundamental Rating

DK gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 213 industry peers in the Oil, Gas & Consumable Fuels industry. Both the profitability and financial health of DK have multiple concerns. DK does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year DK has reported negative net income.

In the past year DK has reported a negative cash flow from operations.

In multiple years DK reported negative net income over the last 5 years.

In multiple years DK reported negative operating cash flow during the last 5 years.

1.2 Ratios

DK's Return On Assets of -10.18% is on the low side compared to the rest of the industry. DK is outperformed by 84.04% of its industry peers.

DK has a Return On Equity of -450.77%. This is amonst the worse of the industry: DK underperforms 92.02% of its industry peers.

		Industry Rank	Sector Rank
ROA	-10.18%
ROE	-450.77%
ROIC	N/A

ROA(3y)-1.66%

ROA(5y)-3.36%

ROE(3y)-49.86%

ROE(5y)-44.86%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for DK so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

DK does not have a ROIC to compare to the WACC, probably because it is not profitable.

DK has less shares outstanding than it did 1 year ago.

The number of shares outstanding for DK has been reduced compared to 5 years ago.

Compared to 1 year ago, DK has a worse debt to assets ratio.

2.2 Solvency

DK has an Altman-Z score of 1.43. This is a bad value and indicates that DK is not financially healthy and even has some risk of bankruptcy.

With a Altman-Z score value of 1.43, DK perfoms like the industry average, outperforming 53.05% of the companies in the same industry.

DK has a Debt/Equity ratio of 19.47. This is a high value indicating a heavy dependency on external financing.

DK has a worse Debt to Equity ratio (19.47) than 92.02% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	19.47
Debt/FCF	N/A
Altman-Z	1.43

ROIC/WACCN/A

WACC8.9%

2.3 Liquidity

DK has a Current Ratio of 0.85. This is a bad value and indicates that DK is not financially healthy enough and could expect problems in meeting its short term obligations.

With a Current ratio value of 0.85, DK is not doing good in the industry: 66.67% of the companies in the same industry are doing better.

A Quick Ratio of 0.53 indicates that DK may have some problems paying its short term obligations.

The Quick ratio of DK (0.53) is worse than 78.87% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.85
Quick Ratio	0.53

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

DK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -728.70%.

DK shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -29.23%.

DK shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.97% yearly.

EPS 1Y (TTM)-728.7%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-465.85%

Revenue 1Y (TTM)-29.23%

Revenue growth 3Y3.64%

Revenue growth 5Y4.97%

Sales Q2Q%-18.15%

3.2 Future

Based on estimates for the next years, DK will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.63% on average per year.

The Revenue is expected to decrease by -4.39% on average over the next years.

EPS Next Y8.2%

EPS Next 2Y24.73%

EPS Next 3Y16.22%

EPS Next 5Y17.63%

Revenue Next Year-12.41%

Revenue Next 2Y-7.16%

Revenue Next 3Y-4.39%

Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DK. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DK. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as DK's earnings are expected to grow with 16.22% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y24.73%

EPS Next 3Y16.22%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.78%, DK is a good candidate for dividend investing.

DK's Dividend Yield is a higher than the industry average which is at 6.42.

Compared to an average S&P500 Dividend Yield of 2.44, DK pays a better dividend.

		Industry Rank	Sector Rank
Dividend Yield	4.78%

5.2 History

The dividend of DK decreases each year by -2.40%.

DK has been paying a dividend for at least 10 years, so it has a reliable track record.

DK has decreased its dividend in the last 3 years.

Dividend Growth(5Y)-2.4%

Div Incr Years2

Div Non Decr Years2

5.3 Sustainability

DK has negative earnings and hence a negative payout ratio. The dividend may be in danger.

DP-9.19%

EPS Next 2Y24.73%

EPS Next 3Y16.22%

More info and screens

Find the best dividend stocks

Show peers with best dividend

DELEK US HOLDINGS INC

NYSE:DK (6/23/2025, 8:04:00 PM)

After market: 21.27 +0.38 (+1.82%)

20.89

-0.88 (-4.04%)

Chartmill FA Rating

GICS SectorEnergy

GICS IndustryGroupEnergy

GICS IndustryOil, Gas & Consumable Fuels

Earnings (Last)05-07 2025-05-07/bmo

Earnings (Next)08-04 2025-08-04/bmo

Inst Owners116.68%

Inst Owner Change-0.14%

Ins Owners2.56%

Ins Owner Change4.35%

Market Cap1.27B

Analysts51.82

Price Target16.44 (-21.3%)

Short Float %14.51%

Short Ratio5.08

Dividend

		Industry Rank	Sector Rank
Dividend Yield	4.78%

Yearly Dividend1.01

Dividend Growth(5Y)-2.4%

DP-9.19%

Div Incr Years2

Div Non Decr Years2

Ex-Date05-12 2025-05-12 (0.255)

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)9.66%

Min EPS beat(2)6.94%

Max EPS beat(2)12.39%

EPS beat(4)4

Avg EPS beat(4)15.96%

Min EPS beat(4)6.94%

Max EPS beat(4)31.66%

EPS beat(8)7

Avg EPS beat(8)19.75%

EPS beat(12)10

Avg EPS beat(12)12.49%

EPS beat(16)14

Avg EPS beat(16)56.29%

Revenue beat(2)0

Avg Revenue beat(2)-6.47%

Min Revenue beat(2)-10.53%

Max Revenue beat(2)-2.4%

Revenue beat(4)1

Avg Revenue beat(4)-5.26%

Min Revenue beat(4)-10.53%

Max Revenue beat(4)0.4%

Revenue beat(8)4

Avg Revenue beat(8)4.73%

Revenue beat(12)8

Avg Revenue beat(12)14.95%

Revenue beat(16)12

Avg Revenue beat(16)15.81%

PT rev (1m)3.5%

PT rev (3m)-17.17%

EPS NQ rev (1m)-36.87%

EPS NQ rev (3m)-39.93%

EPS NY rev (1m)-4.9%

EPS NY rev (3m)-24.64%

Revenue NQ rev (1m)1.51%

Revenue NQ rev (3m)3.33%

Revenue NY rev (1m)0.45%

Revenue NY rev (3m)-0.67%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.11
P/FCF	N/A
P/OCF	N/A
P/B	8.16
P/tB	N/A
EV/EBITDA	N/A

EPS(TTM)-7.23

EYN/A

EPS(NY)-2.36

Fwd EYN/A

FCF(TTM)-13.48

FCFYN/A

OCF(TTM)-4.87

OCFYN/A

SpS189.03

BVpS2.56

TBVpS-11.9

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-10.18%
ROE	-450.77%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM	N/A

ROA(3y)-1.66%

ROA(5y)-3.36%

ROE(3y)-49.86%

ROE(5y)-44.86%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score1

Asset Turnover1.67

Health

		Industry Rank	Sector Rank
Debt/Equity	19.47
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	137.39%
Cap/Sales	4.56%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.85
Quick Ratio	0.53
Altman-Z	1.43

F-Score1

WACC8.9%

ROIC/WACCN/A

Cap/Depr(3y)115.33%

Cap/Depr(5y)106.41%

Cap/Sales(3y)2.6%

Cap/Sales(5y)2.73%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-728.7%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-465.85%

EPS Next Y8.2%

EPS Next 2Y24.73%

EPS Next 3Y16.22%

EPS Next 5Y17.63%

Revenue 1Y (TTM)-29.23%

Revenue growth 3Y3.64%

Revenue growth 5Y4.97%

Sales Q2Q%-18.15%

Revenue Next Year-12.41%

Revenue Next 2Y-7.16%

Revenue Next 3Y-4.39%

Revenue Next 5YN/A

EBIT growth 1Y-319.68%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year306.97%

EBIT Next 3Y73.69%

EBIT Next 5Y43.1%

FCF growth 1Y-376.06%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-137.29%

OCF growth 3YN/A

OCF growth 5YN/A

DELEK US HOLDINGS INC (DK) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens